【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2921次   下载 2147 本文二维码信息
码上扫一扫!
促性腺激素释放激素类似物逆转卵巢癌细胞对顺铂的耐药性
王丹,惠宁*,吴东
0
(第二军医大学长海医院妇产科,上海 200433)
摘要:
研究促性腺激素释放激素(GnRH)类似物曲谱瑞林(triptorelin)体外逆转卵巢癌细胞顺铂耐药的效果,并探讨其作用机制。方法:体外建立卵巢癌顺铂耐药细胞系模型OVCAR-3/CDDP; MTT法检测单独使用曲谱瑞林或顺铂及两药联合使用时对OVCAR-3/CDDP细胞的抑制作用;流式细胞术检测不同加药组细胞的表皮生长因子受体(epidermal growth factor receptor,EGFR)表达改变。结果:(1)卵巢癌OVCAR-3/CDDP细胞耐药指数为13.42;(2)顺铂与曲谱瑞林联合化疗逆转倍数为3.91;(3)OVCAR-3/CDDP细胞EGFR表达在两药联合处理组降低最明显。结论:曲谱瑞林能部分逆转OVCAR-3/CDDP细胞对顺铂的耐药性,且此作用可能与下调细胞EGFR表达有关。
关键词:  曲谱瑞林  卵巢肿瘤  顺铂  耐药性
DOI:10.3724/SP.J.1008.2008.00395
投稿时间:2008-03-28修订日期:2008-03-28
基金项目:
GnRH analog resensitizes cisplatin-resistant human ovarian cancer cells
WANG Dan,HUI Ning*,WU Dong
(Department of Gynecology and Obstetrics,Changhai Hospital,Second Military Medical University,Shanghai 200433, China)
Abstract:
Objective:To study the effect of GnRH analog triptorelin in resensitizing cisplatin-resistant human ovarian cancer cells and to discuss the related mechanism. Methods: Cisplatin-resistant human ovarian cancer cell line OVCAR-3/CDDP was established in vitro. MTT assay was used to assess the inhibitory effects of triptorelin, cisplatin alone or a combination of both on OVCAR-3/CDDP cells. Flow cytometry was employed to observe the expression changes in epidermal growth factor receptor (EGFR) in different groups. Results: The drug restant index of OVCAR-3/CDDP cells was 13.42. The resensitizing fold of cisplatin combined with triptorelin was 3.80. The expression of EGFR had the most prominent decrease in OVCAR-3/CDDP cells in the combination group. Conclusion: Triptorelin can partially resensitize cisplatin-resistant OVCAR-3/CDDP cells, which might be related to the down-regulation of EGFR.
Key words:  triptorelin  ovarian neoplasms  cisplatin  drug tolerance